Luc Furic
Monash University
H-index: 33
Oceania-Australia
Top articles of Luc Furic
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
PMR-116, a second generation RNA Polymerase I inhibitor | Cancer Research | Luc Furic Nadine Hein Rita Ferreira Konstantin Panov Alisee Huglo | 2024/3/22 |
Abstract A176: Loss of SMAD4 unleashes mTOR and increases dependency on cap-dependent translation in esophageal tumorigenesis | Molecular Cancer Therapeutics | Julia V Milne Ebtihal Mustafa Kenji Fujihara Eric Kusnadi Niko Thio | 2023/12/1 |
LuCAB: A phase I/II trial evaluating cabazitaxel in combination with [177Lu]Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer … | Louise Kathleen Kostos James Patrick Buteau Grace Kong Theresa Yeung Juliana Di Iulio | 2023/2/20 | |
Abstract PR006: PMR-116, a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer | Cancer Research | Alisee Huglo Shelley Hedwards Mitchell Lawrence Richard Rebello Ashlee Clark | 2023/6/2 |
AlphaBet: A phase I/II trial evaluating the combination of radium-223 and [177Lu]Lu-PSMA-I&T in patients (pts) with metastatic castration-resistant prostate cancer … | Louise Kathleen Kostos James Patrick Buteau Theresa Yeung Sophia Xie Juliana Di Iulio | 2023/2/20 | |
VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [161Tb]Tb-PSMA-I&T. | James Patrick Buteau Louise Kathleen Kostos Ramin Alipour Price Jackson Lachlan McIntosh | 2023/2/20 | |
Genomic aberrations in circulating tumor DNA (ctDNA) and clinical outcomes from [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC) | Cancer Research | Heidi Fettke Louise Kostos James Buteau Jason A Steen Elizabeth Medhurst | 2023/4/4 |
Arginine-rich C9ORF72 ALS proteins stall ribosomes in a manner distinct from a canonical ribosome-associated quality control substrate | Journal of Biological Chemistry | Viacheslav Kriachkov Angelique R Ormsby Eric P Kusnadi Hamish EG McWilliam Justine D Mintern | 2023/1/1 |
AlphaBet: Combination of Radium-and [Lu] Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial | Targeted alpha particle therapy in oncology | Louise Kostos James P Buteau Theresa Yeung Juliana Di Iulio Jing Xie | 2023/3/30 |
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells | Nature Communications | Yuchen Bai Carolin Gotz Ginevra Chincarini Zixuan Zhao Clare Slaney | 2023/3/22 |
PMR-116, a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer | Cancer Research | Alisee Huglo Richard Rebello Mitchell Lawrence Gail Risbridger Denis Drygin | 2022/6/15 |
Regulation of gene expression via translational buffering | Eric P Kusnadi Clelia Timpone Ivan Topisirovic Ola Larsson Luc Furic | 2022/1/1 | |
AlphaBet: combination of radium-223 and [177Lu] Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol) | Frontiers in medicine | Louise Kostos James P Buteau Theresa Yeung Juliana Di Iulio Jing Xie | 2022/11/18 |
Mast cell-derived SAMD14 is a novel regulator of the human prostate tumor microenvironment | Cancers | Linda KH Teng Brooke A Pereira Shivakumar Keerthikumar Cheng Huang Birunthi Niranjan | 2021/3/11 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Daniel J Klionsky Amal Kamal Abdel-Aziz Sara Abdelfatah Mahmoud Abdellatif Asghar Abdoli | 2021/1/2 | |
CX-5461 sensitizes DNA damage repair–proficient castrate-resistant prostate cancer to PARP inhibition | Molecular cancer therapeutics | Mitchell G Lawrence Laura H Porter Nicholas Choo David Pook Jeremy P Grummet | 2021/11/1 |
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology | Nature communications | Gail P Risbridger Ashlee K Clark Laura H Porter Roxanne Toivanen Andrew Bakshi | 2021/8/19 |
Regulation of mRNA translation by hormone receptors in breast and prostate cancer | Jianling Xie Eric P Kusnadi Luc Furic Luke A Selth | 2021/6/29 | |
The protective role of podocyte hypertrophy via mtor signalling after mild podocyte depletion. | L Furic MJ Moeller DJ Nikolic-Paterson JF Bertram KM Denton | 2020/12/22 | |
Inhibition of the lysophosphatidylinositol transporter ABCC1 reduces prostate cancer cell growth and sensitizes to chemotherapy | Cancers | Aikaterini Emmanouilidi Ilaria Casari Begum Gokcen Akkaya Tania Maffucci Luc Furic | 2020/8 |
Co-Authors
